The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Edwards Mark G since 2011.
The trader's CIK number is 1190429.
At the time of the last reporting, Edwards Mark G was the Director of Acelrx Pharmaceuticals Inc. (stock ticker symbol ACRX).
Also see all insider trading activities at Acelrx Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | ACRX | 59,000 | $134,271 | 0 | $0 | 0 | $0 |
2018 | ACRX | 31,000 | $90,171 | 0 | $0 | 0 | $0 |
2017 | ACRX | 35,000 | $72,070 | 0 | $0 | 0 | $0 |
2016 | ACRX | 15,000 | $47,250 | 0 | $0 | 0 | $0 |
2015 | ACRX | 40,000 | $125,120 | 0 | $0 | 0 | $0 |
2013 | ACRX | 10,000 | $81,000 | 0 | $0 | 0 | $0 |
2011 | ACRX | 50,000 | $143,900 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-11-12 | ACRX | Buy | 25,000 | 1.78 | 44,575 |
2019-08-23 | ACRX | Buy | 10,000 | 2.20 | 21,960 |
2019-08-26 | ACRX | Buy | 5,000 | 2.17 | 10,850 |
2019-03-12 | ACRX | Buy | 19,000 | 2.99 | 56,886 |
2018-11-15 | ACRX | Buy | 20,700 | 2.82 | 58,374 |
2018-08-07 | ACRX | Buy | 5,300 | 2.84 | 15,062 |
2018-06-01 | ACRX | Buy | 300 | 3.30 | 990 |
2018-06-05 | ACRX | Buy | 4,700 | 3.35 | 15,745 |
2017-11-14 | ACRX | Buy | 30,000 | 1.90 | 56,970 |
2017-08-22 | ACRX | Buy | 200 | 2.90 | 580 |
2017-08-24 | ACRX | Buy | 4,800 | 3.02 | 14,520 |
2016-05-10 | ACRX | Buy | 5,000 | 3.25 | 16,250 |
2016-05-11 | ACRX | Buy | 5,000 | 3.15 | 15,750 |
2016-05-12 | ACRX | Buy | 5,000 | 3.05 | 15,250 |
2015-05-07 | ACRX | Buy | 40,000 | 3.13 | 125,120 |
2013-06-06 | ACRX | Buy | 10,000 | 8.10 | 81,000 |
2011-12-01 | ACRX | Buy | 10,000 | 2.79 | 27,900 |
2011-11-14 | ACRX | Buy | 40,000 | 2.90 | 116,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Edwards Mark G (Director of Acelrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.